Safety during crisis: Rapid on-site evaluation at the time of COVID-19 pandemic.
Diagn Cytopathol
; 48(8): 813-815, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-245147
ABSTRACT
The COVID-19 pandemic is posing a worldwide challenge to control and contain. SARS-CoV-2 is a highly infectious virus. Health care providers at the front lines are at high risk of getting the infection and the risk applies also to laboratory personnel as they deal with specimens that might be contaminated with infectious materiel. Cytopathology teams specifically are at high risk of dealing with contaminated material because of patients encounter during fine-needle aspiration biopsies or Rapid On-Site Evaluation (ROSE) for adequacy. In our article, we discuss alternative safer staining methods to the widely used Diff-Quick stain that can be utilized for ROSE to decrease the risk of viral exposure during the current COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Staining and Labeling
/
Occupational Health
/
Medical Laboratory Personnel
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Diagn Cytopathol
Journal subject:
Pathology
Year:
2020
Document Type:
Article
Affiliation country:
Dc.24453
Similar
MEDLINE
...
LILACS
LIS